Moreover, this work is the first to elucidate the kinase targets of dasatinib in GC (SRC, ABL2, DDR1, EPHB2, FRK, LYN, RIPK, SRC, SIK2, YES1 and EPHA2). This evidence concerns the gene DDR1 and gastric cancer.